最新研究结果对用于治疗抗精神病药物所致体重增加的行为学方法提出了挑战。
Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain.
作者信息
Kisely Steve, Siskind Dan, Speyer Helene
机构信息
School of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia.
出版信息
BJPsych Open. 2025 Apr 10;11(3):e85. doi: 10.1192/bjo.2025.34.
Abstract
Obesity is a major health problem among people with severe mental illness, linked to increased risk of chronic diseases and reduced life expectancy. This is attributable to a combination of factors, including lifestyle, social circumstances, medication side-effects and the illness itself. Second-generation antipsychotics are particularly associated with weight gain, affecting treatment adherence, symptoms and quality of life.
摘要
肥胖是重度精神疾病患者中的一个主要健康问题，与慢性病风险增加和预期寿命缩短有关。这可归因于多种因素的综合作用，包括生活方式、社会环境、药物副作用和疾病本身。第二代抗精神病药物尤其与体重增加有关，会影响治疗依从性、症状和生活质量。
相似文献
1
Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain.
BJPsych Open. 2025 Apr 10;11(3):e85. doi: 10.1192/bjo.2025.34.
2
[Antipsychotics in bipolar disorders].
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
3
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.
Neuropsychiatr Dis Treat. 2017 Aug 22;13:2231-2241. doi: 10.2147/NDT.S113099. eCollection 2017.
4
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial.
BMC Psychiatry. 2021 Jan 5;21(1):4. doi: 10.1186/s12888-020-02992-4.
5
Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management.
Adolesc Health Med Ther. 2014 Sep 26;5:171-82. doi: 10.2147/AHMT.S49807. eCollection 2014.
6
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
7
Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16.
8
Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk.
Australas Psychiatry. 2017 Aug;25(4):387-390. doi: 10.1177/1039856217695704. Epub 2017 Mar 1.
9
[Metabolic side effects of risperidone in early onset schizophrenia].
Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1.
10
Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
Int J Ment Health Nurs. 2011 Dec;20(6):428-37. doi: 10.1111/j.1447-0349.2011.00747.x. Epub 2011 May 12.
本文引用的文献
1
Informing the development of antipsychotic-induced weight gain management guidance: patient experiences and preferences - qualitative descriptive study.
BJPsych Open. 2024 Aug 1;10(5):e136. doi: 10.1192/bjo.2024.725.
2
Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: A systematic review and meta-analysis.
Acta Psychiatr Scand. 2024 Dec;150(6):516-529. doi: 10.1111/acps.13734. Epub 2024 Jul 24.
3
Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists.
JAMA. 2024 Jul 2;332(1):16-18. doi: 10.1001/jama.2024.7062.
4
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Cochrane Database Syst Rev. 2022 Oct 3;10(10):CD013337. doi: 10.1002/14651858.CD013337.pub2.
5
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis.
Schizophr Bull. 2021 Jul 8;47(4):948-958. doi: 10.1093/schbul/sbaa191.
6
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia.
Expert Opin Drug Saf. 2019 Dec;18(12):1149-1160. doi: 10.1080/14740338.2019.1674809. Epub 2019 Oct 11.
7
Lifestyle Interventions for Weight Management in People with Serious Mental Illness: A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects.
Psychother Psychosom. 2019;88(6):350-362. doi: 10.1159/000502293. Epub 2019 Sep 13.
8
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.
Diabetes Obes Metab. 2019 Feb;21(2):293-302. doi: 10.1111/dom.13522. Epub 2018 Oct 7.
9
Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysis.
J Psychiatr Res. 2018 Jul;102:245-253. doi: 10.1016/j.jpsychires.2018.04.019. Epub 2018 Apr 26.
10
Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
PLoS One. 2016 Jun 15;11(6):e0156208. doi: 10.1371/journal.pone.0156208. eCollection 2016.
Zotero 插件